Roche out-licneses lebrikizumab to Dermira
admin 9th August 2017 Uncategorised 0Deal could be worth at least $1.4 billion
More: Roche out-licneses lebrikizumab to Dermira
Source: News
Deal could be worth at least $1.4 billion
More: Roche out-licneses lebrikizumab to Dermira
Source: News
© 1994 - 2024 B.M. Pharmaceuticals